Potassium Chloride recalls
Potassium Chloride products have been recalled 17 times, most recently on 26 Nov 2025. The recalling company is usually Glenmark Pharmaceuticals Inc., USA. The most common reason is potency & assay.
Total recalls 17 since 2014
Last 12 months 2 reported
Class I 8 47% of total
Ongoing 10 latest 26 Nov 2025
Recalls per month, last 24 months click a bar for that month
Severity split
Class I 8 47% Class II 8 47% Class III 1 6%
Why potassium chloride is recalled
Ongoing potassium chloride recalls 10 active
All potassium chloride recalls, newest first 17 total
Reported Class Recall Company Reason Where 26 Nov 2025 Drug CLASS I Potassium Chloride Inj., 20 mEq total in Flexible Container recalled Potassium Chloride Otsuka ICU Medical Other Nationwide 26 Nov 2025 Drug CLASS I Potassium Chloride Inj., 10 mEq total in Flexible Container recalled Potassium Chloride Otsuka ICU Medical Other Nationwide 19 Mar 2025 Drug CLASS I Potassium Chloride Inj., 20 mEq total in flexible container recalled Potassium Chloride ICU Medical Labeling Errors Nationwide 19 Mar 2025 Drug CLASS I Potassium Chloride Inj., 10 mEq total recalled by ICU Medical Potassium Chloride ICU Medical Other Nationwide 12 Feb 2025 Drug CLASS II Potassium Chloride Extended-Release Tablets, USP, 10 mEq recalled Potassium Chloride The Harvard Drug Group Potency & Assay Nationwide 7 Aug 2024 Drug CLASS I Potassium Chloride Extended-Release Capsules recalled Potassium Chloride Amerisource Health Services Potency & Assay Nationwide 24 Jul 2024 Drug CLASS II Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq recalled Potassium Chloride Glenmark Pharmaceuticals Inc., USA Manufacturing (CGMP) Deviations Nationwide 24 Jul 2024 Drug CLASS I Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq recalled Potassium Chloride Glenmark Pharmaceuticals Inc., USA Potency & Assay Nationwide 24 Jul 2024 Drug CLASS I Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq recalled Potassium Chloride Glenmark Pharmaceuticals Inc., USA Potency & Assay Nationwide 24 Jul 2024 Drug CLASS II Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq recalled Potassium Chloride Glenmark Pharmaceuticals Inc., USA Manufacturing (CGMP) Deviations Nationwide 20 Mar 2024 Drug CLASS II Potassium Chloride for Injection Concentrate USP, 500 mEq recalled Potassium Chloride B. Braun Medical Sterility Nationwide 20 Oct 2021 Drug CLASS II Potassium Chloride Extended-Release Tablets, USP 10 mEq (750 mg) recalled Potassium Chloride Strides Pharma Potency & Assay Nationwide 7 Oct 2020 Drug CLASS II Pharma Inc.Potassium Chloride Extended-Release Tablets recalled Potassium Chloride Strides Potency & Assay Nationwide 25 Mar 2020 Drug CLASS III Potassium Chloride Extended-Release Tablets USP, 10mEq (750mg) recalled Potassium Chloride Strides Pharma Science Other Nationwide 3 Dec 2014 Drug CLASS II Potassium Chloride Injection recalled by Baxter Healthcare Potassium Chloride Baxter Healthcare Other Nationwide 1 Oct 2014 Drug CLASS II Potassium Chloride Injection, 10 mEq recalled by Baxter Healthcare Potassium Chloride Baxter Healthcare Packaging Defects Nationwide 24 Sep 2014 Drug CLASS I Potassium Chloride Injection recalled by Baxter Healthcare Potassium Chloride Baxter Healthcare Particulate Matter Nationwide
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.